prevacid solutab patients clarithromycin ulcer prevpac
Jan. 8, 2008 -- An experimental weight loss medication in the same class as the drug Acomplia helped patients lose weight in a 12-week, phase II study, but side effects were common at higher doses. Like Acomplia (rimonabant), which is approved for sale in Europe but not in the U. S., the Merck & Co.drug taranabant targets receptors in the brain linked to appetite. Concerns about reports of anxiety and depression in rimonabant users have kept the drug off the market in the U. S. Based on these reports, an FDA advisory panel voted against recommending its approval last June, prompting manufacturer Sanofi-Aventis to withdraw its application to the agency. Depression and anxiety were also reported in the taranabant study, but these side effects were most common at the highest doses given, researcher Steven Heymsfield, MD, of Merck Research Laboratories, tells WebMD. why is prevacid so expensive prevacid rectal prevacid diarrhea prevacid package insert prevacid 30 mg